KYORIN Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3247090008
JPY
1,498.00
6 (0.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
30,229.00
40,801.00
34,147.00
26,720.00
28,419.00
32,265.00
32,330.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
30,229.00
40,801.00
34,147.00
26,720.00
28,419.00
32,265.00
32,330.00
Raw Material Cost
16,970.00
19,942.00
19,044.00
15,508.00
16,073.00
19,173.00
17,663.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
64.00
70.00
49.00
36.00
18.00
17.00
16.00
Selling and Distribution Expenses
8,901.00
8,952.00
9,330.00
9,040.00
9,131.00
9,237.00
9,480.00
Other Expenses
192.70
238.90
416.20
173.80
205.20
229.20
185.20
Total Expenditure (Excl Depreciation)
27,862.00
31,353.00
32,585.00
26,322.00
27,274.00
30,719.00
29,011.00
Operating Profit (PBDIT) excl Other Income
2367
9448
1562
398
1145
1546
3319
Other Income
326.00
27.00
189.00
260.00
235.00
258.00
368.00
Operating Profit (PBDIT)
3,833.00
10,652.00
2,870.00
1,783.00
2,562.00
2,868.00
4,741.00
Interest
64.00
70.00
49.00
36.00
18.00
17.00
16.00
Exceptional Items
100.00
-204.00
-2.00
-58.00
-55.00
83.00
-871.00
Gross Profit (PBDT)
13,259.00
20,859.00
15,103.00
11,212.00
12,346.00
13,092.00
14,667.00
Depreciation
1,140.00
1,177.00
1,119.00
1,125.00
1,182.00
1,064.00
1,054.00
Profit Before Tax
2,728.00
9,201.00
1,700.00
564.00
1,305.00
1,869.00
2,801.00
Tax
628.00
2,554.00
517.00
194.00
419.00
461.00
644.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,100.00
6,647.00
1,184.00
370.00
885.00
1,408.00
2,157.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,100.00
6,647.00
1,184.00
370.00
885.00
1,408.00
2,157.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,100.00
6,647.00
1,184.00
370.00
885.00
1,408.00
2,157.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,36,153.00
1,36,285.00
1,30,073.00
1,30,027.00
1,30,047.00
1,30,783.00
1,26,576.00
Earnings per share (EPS)
36.55
115.7
20.61
6.44
15.41
24.51
37.55
Diluted Earnings per share
36.55
115.7
20.61
6.44
15.41
24.51
37.55
Operating Profit Margin (Excl OI)
7.83%
23.16%
4.57%
1.49%
4.03%
4.79%
10.27%
Gross Profit Margin
12.8%
25.44%
8.26%
6.32%
8.75%
9.09%
11.92%
PAT Margin
6.95%
16.29%
3.47%
1.38%
3.11%
4.36%
6.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is -25.91% vs 19.49% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -68.41% vs 461.40% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -66.99% vs 296.31% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -8.57% vs 42.86% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of KYORIN Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
30,229.00
8,450.00
21,779.00
257.74%
Other Operating Income
0.00
0.00
0.00
Total Operating income
30,229.00
8,450.00
21,779.00
257.74%
Raw Material Cost
16,970.00
1,858.00
15,112.00
813.35%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
64.00
1,258.00
-1,194.00
-94.91%
Selling and Distribution Expenses
8,901.00
3,865.00
5,036.00
130.30%
Other Expenses
192.70
240.80
-48.10
-19.98%
Total Expenditure (Excl Depreciation)
27,862.00
9,389.00
18,473.00
196.75%
Operating Profit (PBDIT) excl Other Income
2,367.00
-939.00
3,306.00
352.08%
Other Income
326.00
631.00
-305.00
-48.34%
Operating Profit (PBDIT)
3,833.00
787.00
3,046.00
387.04%
Interest
64.00
1,258.00
-1,194.00
-94.91%
Exceptional Items
100.00
0.00
100.00
Gross Profit (PBDT)
13,259.00
6,592.00
6,667.00
101.14%
Depreciation
1,140.00
1,095.00
45.00
4.11%
Profit Before Tax
2,728.00
-1,566.00
4,294.00
274.20%
Tax
628.00
811.00
-183.00
-22.56%
Provisions and contingencies
0
0
0.00
Profit After Tax
2,100.00
-2,377.00
4,477.00
188.35%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,100.00
-2,377.00
4,477.00
188.35%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,100.00
-2,377.00
4,477.00
188.35%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,36,153.00
65,861.00
70,292.00
106.73%
Earnings per share (EPS)
36.55
-26.38
62.93
238.55%
Diluted Earnings per share
36.55
-26.38
62.93
238.55%
Operating Profit Margin (Excl OI)
7.83%
-11.11%
0.00
18.94%
Gross Profit Margin
12.80%
-5.57%
0.00
18.37%
PAT Margin
6.95%
-28.13%
0.00
35.08%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3,022.90 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -25.91% vs 19.49% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 6.37% vs 2.03% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 210.00 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -68.41% vs 461.40% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 137.29% vs 30.92% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 350.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -66.99% vs 296.31% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 50.71% vs 28.92% in Jun 2024

Quarterly - Interest
Interest 6.40 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -8.57% vs 42.86% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 255.56% vs 12.50% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.83%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024